Steven Cohen’s Neuronetics STIM Stock Holding History

Steven Cohen’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-68	Closed	-$198	–	2750
2023 Q1	$198	Buy	+68	New	+$343	﹤0.01%	2152
2019 Q1	–	Sell	-378,359	Closed	-$7.32M	–	1223
2018 Q4	$7.32M	Buy	378,359 +136,507	+56%	+$3M	0.04%	468
2018 Q3	$7.75M	Buy	241,852 +211,852	+706%	+$6.44M	0.03%	505
2018 Q2	$798K	Buy	+30,000	New	+$816K	﹤0.01%	850

Other funds holding STIM

Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $411M AUM 61.05% 1-Year Est. Return

Steven Cohen's STIM Position: Q2 2023 in Review

Steven Cohen sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 68 shares — an estimated $198 sold.

Steven Cohen first reported a position in STIM in Q2 2018 and held it in 4 quarters. The position peaked at $7.75M in Q3 2018. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

Steven Cohen reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
Steven Cohen sold 68 Neuronetics shares in Q2 2023, an estimated $198.
Steven Cohen first reported a position in Neuronetics in Q2 2018 and held it in 4 quarters.
Steven Cohen's Neuronetics position peaked at $7.75M in Q3 2018.
69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.